These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 21446979)

  • 1. Characterization of HCV-specific CD4+Th17 immunity in recurrent hepatitis C-induced liver allograft fibrosis.
    Basha HI; Subramanian V; Seetharam A; Nath DS; Ramachandran S; Anderson CD; Shenoy S; Chapman WC; Crippin JS; Mohanakumar T
    Am J Transplant; 2011 Apr; 11(4):775-85. PubMed ID: 21446979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Donor graft steatosis influences immunity to hepatitis C virus and allograft outcome after liver transplantation.
    Subramanian V; Seetharam AB; Vachharajani N; Tiriveedhi V; Angaswamy N; Ramachandran S; Crippin JS; Shenoy S; Chapman WC; Mohanakumar T; Anderson CD
    Transplantation; 2011 Dec; 92(11):1259-68. PubMed ID: 22011763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of virus-specific T-cell immunity in liver allograft recipients with HCV-induced cirrhosis.
    Bharat A; Barros F; Narayanan K; Borg B; Lisker-Melman M; Shenoy S; Lowell J; Crippin J; Chapman W; Mohanakumar T
    Am J Transplant; 2008 Jun; 8(6):1214-20. PubMed ID: 18522547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated soluble CD30 characterizes patients with hepatitis C virus-induced liver allograft cirrhosis.
    Bharat A; Narayanan K; Golocheikine A; Steward N; Crippin J; Lisker-Melman M; Shenoy S; Lowell J; Chapman WC; Mohanakumar T
    Transplantation; 2007 Dec; 84(12):1704-7. PubMed ID: 18165785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temporal association between increased virus-specific Th17 response and spontaneous recovery from recurrent hepatitis C in a liver transplant recipient.
    Seetharam AB; Borg BB; Subramanian V; Chapman WC; Crippin JS; Mohanakumar T
    Transplantation; 2011 Dec; 92(12):1364-70. PubMed ID: 22082818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrent hepatitis C virus infection after liver transplantation--long-term follow-up with respect to the HCV genotypes/subtypes.
    Arnold JC; Töx U; Goeser T; Otto G; Müller HM; Hofmann WJ; Stremmel W; Theilmann L
    Z Gastroenterol; 1997 Apr; 35(4):255-61. PubMed ID: 9163889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of recurrent HCV infection after liver transplantation].
    Ostojić R
    Acta Med Croatica; 2005; 59(5):443-6. PubMed ID: 16381241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathological Roles of Interleukin-22 in the Development of Recurrent Hepatitis C after Liver Transplantation.
    Gao Y; Ren H; Meng F; Li J; Cheung E; Li H; Zhao J; Liu H; Liu Z; Zhang M
    PLoS One; 2016; 11(4):e0154419. PubMed ID: 27123854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [HCV reinfection after liver transplantation for HCV cirrhosis].
    Pasquale G; Iannicelli P; Martini S; Mogavero AR; Caprio N
    Infez Med; 2005 Dec; 13(4):215-28. PubMed ID: 16388277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokine profile of liver- and blood-derived nonspecific T cells after liver transplantation: T helper cells type 1/0 lymphokines dominate in recurrent hepatitis C virus infection and rejection.
    Schirren CA; Jung M; Worzfeld T; Mamin M; Baretton GB; Gruener NH; Gerlach JT; Diepolder HM; Zachoval R; Pape GR
    Liver Transpl; 2000 Mar; 6(2):222-8. PubMed ID: 10719024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perioperative blood transfusion affects hepatitis C virus (HCV)-specific immune responses and outcome following liver transplantation in HCV-infected patients.
    Subramanian V; Bharat A; Vachharajani N; Crippin J; Shenoy S; Mohanakumar T; Chapman WC
    HPB (Oxford); 2014 Mar; 16(3):282-94. PubMed ID: 23869514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Humoral immune response to hepatitis C after liver transplantation: assessment of a new recombinant immunoblot assay.
    Rosen HR; Gretch D; Kaufman E; Quan S
    Am J Gastroenterol; 2000 Aug; 95(8):2035-9. PubMed ID: 10950054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful treatment of fibrosing cholestatic hepatitis after liver transplantation.
    Cimsit B; Assis D; Caldwell C; Arvelakis A; Taddei T; Kulkarni S; Schilsky M; Emre S
    Transplant Proc; 2011 Apr; 43(3):905-8. PubMed ID: 21486625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The imbalance between Tregs, Th17 cells and inflammatory cytokines among renal transplant recipients.
    Ma L; Zhang H; Hu K; Lv G; Fu Y; Ayana DA; Zhao P; Jiang Y
    BMC Immunol; 2015 Sep; 16():56. PubMed ID: 26400627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring peripheral blood CD4+ adenosine triphosphate activity in recurrent hepatitis C and its correlation to fibrosis progression.
    Alkhouri N; Hanouneh IA; Lopez R; Zein NN
    Liver Transpl; 2010 Feb; 16(2):155-62. PubMed ID: 20104483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating FoxP3+ Regulatory T and Interleukin17-Producing Th17 Cells Actively Influence HBV Clearance in De Novo Hepatitis B Virus Infected Patients after Orthotopic Liver Transplantation.
    Gao Y; Zhang M; Li J; Yang M; Liu Y; Guo X; Li H; Liu Z; Zhao J
    PLoS One; 2015; 10(9):e0137881. PubMed ID: 26367459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C-induced hepatic allograft injury is associated with a pretransplantation elevated viral replication rate.
    Pelletier SJ; Raymond DP; Crabtree TD; Berg CL; Iezzoni JC; Hahn YS; Sawyer RG; Pruett TL
    Hepatology; 2000 Aug; 32(2):418-26. PubMed ID: 10915752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated CD4+/CD25+ T-cell frequency and function during hepatitis C virus recurrence after liver transplantation.
    Perrella A; Arenga G; Pisaniello D; Rampone B; Di Costanzo GG; Atripaldi L; Esposito C; Di Florio E; Perrella O; Cuomo O
    Transplant Proc; 2009 Jun; 41(5):1761-6. PubMed ID: 19545723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of replicative senescence in the progression of fibrosis in hepatitis C virus (HCV) recurrence after liver transplantation.
    Trak-Smayra V; Contreras J; Dondero F; Durand F; Dubois S; Sommacale D; Marcellin P; Belghiti J; Degott C; Paradis V
    Transplantation; 2004 Jun; 77(11):1755-60. PubMed ID: 15201678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retransplantation for recurrent hepatitis C.
    Ghobrial RM
    Liver Transpl; 2002 Oct; 8(10 Suppl 1):S38-43. PubMed ID: 12362296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.